Sartorius Stedim Biotech SA (SDMHF)
244.10
+5.10
(+2.13%)
USD |
OTCM |
Oct 28, 16:00
Sartorius Stedim Biotech Market Cap : 23.75B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 23.75B |
| October 27, 2026 | 23.25B |
| October 26, 2026 | 23.25B |
| October 23, 2026 | 23.25B |
| October 22, 2026 | 23.25B |
| October 21, 2026 | 22.80B |
| October 20, 2026 | 22.86B |
| October 19, 2026 | 22.86B |
| October 16, 2026 | 23.55B |
| October 15, 2026 | 23.55B |
| October 14, 2026 | 23.55B |
| October 13, 2026 | 23.55B |
| October 12, 2026 | 23.55B |
| October 09, 2026 | 23.55B |
| October 08, 2026 | 23.74B |
| October 07, 2026 | 23.74B |
| October 06, 2026 | 23.74B |
| October 05, 2026 | 23.74B |
| October 02, 2026 | 23.74B |
| October 01, 2026 | 23.74B |
| September 30, 2026 | 23.74B |
| September 29, 2026 | 23.74B |
| September 28, 2026 | 23.92B |
| September 25, 2026 | 23.58B |
| September 24, 2026 | 23.65B |
| Date | Value |
|---|---|
| September 23, 2026 | 23.53B |
| September 22, 2026 | 22.67B |
| September 21, 2026 | 22.72B |
| September 18, 2026 | 21.77B |
| September 17, 2026 | 21.77B |
| September 16, 2026 | 21.70B |
| September 15, 2026 | 20.43B |
| September 14, 2026 | 20.43B |
| September 11, 2026 | 21.39B |
| September 10, 2026 | 21.39B |
| September 09, 2026 | 22.28B |
| September 08, 2026 | 22.28B |
| September 04, 2026 | 22.28B |
| September 03, 2026 | 22.28B |
| September 02, 2026 | 22.28B |
| September 01, 2026 | 22.28B |
| August 31, 2026 | 22.28B |
| August 28, 2026 | 22.28B |
| August 27, 2026 | 21.12B |
| August 26, 2026 | 21.12B |
| August 25, 2026 | 21.12B |
| August 24, 2026 | 21.12B |
| August 21, 2026 | 21.12B |
| August 20, 2026 | 21.12B |
| August 19, 2026 | 21.12B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agilent Technologies, Inc. | 51.10B |
| Bio-Rad Laboratories, Inc. | 10.27B |
| Bruker Corp. | 9.446B |
| Azenta, Inc. | 1.807B |
| Danaher Corp. | 166.66B |
Market Cap Related Metrics
| PE Ratio | 63.14 |
| PS Ratio | 6.677 |
| PEG Ratio | 2.173 |
| Price to Book Value | 4.776 |
| Price to Free Cash Flow | 76.21 |
| Price | 244.10 |
| Earnings Yield | 1.58% |
| PEGY Ratio | 2.149 |
| Operating PE Ratio | 35.95 |
| Normalized PE Ratio | 54.83 |